VJHemOnc is an official Media Partner for the 1st Texas MPN Workshop which takes place on 27-28 August.

Being held online over two days, the meeting will provide state-of-the-art presentations and interactive discussions for a world-leading myeloproliferative neoplasms (MPNs) faculty.

View all videos

Texas MPN Workshop 2020

The Texas Virtual MPN Workshop 2020
27–28 August 2020 | Virtual Meeting

First results of the 2nd H2H of iBTKs: the ALPINE study. With a 15 months follow up.
So different population from ELEVATE RR #iwCLL2021 @PeterHillmen #CLL

4

⭐@ninashah33 of @UofCalifornia gives us all the latest developments on the use of alloCAR-T therapies ⭐

Watch: 👉http://ow.ly/k1V050G7DAQ👈

@SocietyofHemOnc #SOHO2021 #HemOnc #ImmunoOnc #CART #BloodCancerAwarenessMonth #CancelBloodCancer #BCAM

In advance of our 2nd debate at #iwCLL2021 between Peter Dreger and @drjgauthier, which type of cellular therapy do you prefer for your patients with CLL?

Very nice description of a very difficult clinical situation: Richter’s Transformation with CNS involvement. Presented by @YucaiWangMD @WeiDing3 at #iwCLL2021

Load More...

Texas MPN Workshop 2020

The Texas Virtual MPN Workshop 2020
27–28 August 2020 | Virtual Meeting

VJHemOnc is an official Media Partner for the 1st Texas MPN Workshop which takes place on 27-28 August.

Being held online over two days, the meeting will provide state-of-the-art presentations and interactive discussions for a world-leading myeloproliferative neoplasms (MPNs) faculty.

View all videos

First results of the 2nd H2H of iBTKs: the ALPINE study. With a 15 months follow up.
So different population from ELEVATE RR #iwCLL2021 @PeterHillmen #CLL

4

⭐@ninashah33 of @UofCalifornia gives us all the latest developments on the use of alloCAR-T therapies ⭐

Watch: 👉http://ow.ly/k1V050G7DAQ👈

@SocietyofHemOnc #SOHO2021 #HemOnc #ImmunoOnc #CART #BloodCancerAwarenessMonth #CancelBloodCancer #BCAM

In advance of our 2nd debate at #iwCLL2021 between Peter Dreger and @drjgauthier, which type of cellular therapy do you prefer for your patients with CLL?

Very nice description of a very difficult clinical situation: Richter’s Transformation with CNS involvement. Presented by @YucaiWangMD @WeiDing3 at #iwCLL2021

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter